EpiPen Investigation

EpiPen Investigation

Squitieri & Fearon, LLP is pursuing a class action lawsuit against Mylan Specialty L.P. (“Mylan”) on behalf of consumers who were victimized by Mylan aggressively increasing the price of EpiPen auto-injectors since 2007.

The lawsuit alleges that Mylan required consumers to purchase the EpiPen in pairs or two-packs and raised the retail price from $57 in 2007 to more than $600 today, even though pharmaceutical industry sources estimate each EpiPen can be produced for between $8 and $10. The EpiPen is essential for families with children who have severe allergies to foods like peanuts which can trigger life-threatening allergic reactions.  Mylan also sells a children’s product called EpiPen Jr. which has a retail price matching the adult EpiPen even though it contains half the dosage and is meant for children.

Mylan exploits its monopoly on the EpiPen which delivers lifesaving medicine to fend off allergic reactions.  Mylan’s pricing scheme results in excessive out-of-pocket expenses for the uninsured and those with high-deductible health insurance.  Mylan is currently under investigation by the House Committee on Oversight and Government Reform, the Securities and Exchange Commission, and state regulatory authorities for its EpiPen pricing scheme.

If you or someone you know purchased, including through insurance, an EpiPen, you may be eligible to receive compensation through a class action lawsuit.  Please contact Stephen J. Fearon, Jr. by e-mail at stephen@sfclasslaw.com or by phone at (212) 421-6492.  You can also complete the following form, and someone from the firm will contact you.

 


EpiPen Investigation

    Any information that you submit will be maintained as confidential. If Squitieri & Fearon, LLP, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Squitieri & Fearon, LLP will contact you to discuss the matter and whether to establish an attorney client relationship.